Drug intelligence / Profile preview

Tendocam-Forte

Development stage: Unknown
Lead developer: Cam Neuro Pharma
Modality: Peptides
Administration: Oral

Overview

**Tendocam-Forte** is an oral nutraceutical product from Cam Neuro Pharma described by the company as containing type II collagen peptide with joint-supporting supplements. It is intended to provide nutritional and structural support for cartilage and joint health, including supplemental use in osteoarthritis; no specific molecular target or clinically established pharmacologic mechanism is disclosed. ([camneuropharma.com](https://camneuropharma.com/))

Brand names: Tendocam-Forte
Other names: Collagen Peptide Type II + joint supplementsTendoCam Forte

Beyond the preview

Go deeper on Tendocam-Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tendocam-Forte.

Explore the full profile